EMEA-000239-PIP01-08-M03
Key facts
| Invented name |
Vibativ
|
| Active substance |
Telavancin (hydrochloride)
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0354/2017
|
| PIP number |
EMEA-000239-PIP01-08-M03
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Theravance Biopharma Ireland Ltd.
Tel. +33 174882008
E-mail: marine.lafargue@quintilesims.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|